Comparing two flu vaccines for people living with HIV
Part of Infections, Lungs & breathing clinical trials.
This study compares two types of flu vaccines for people living with HIV to see which one produces a stronger immune response. It may help you get better protection against the flu.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years of age or older
- You are living with HIV
- You have never had a severe allergic reaction to a flu shot (like anaphylaxis) or a rare nerve condition called Guillain-Barré syndrome after a flu vaccine
- You do not have a bleeding disorder that would make an injection unsafe
- You have not already received a flu vaccine for the 2026–2027 season
- You have not been diagnosed with the flu in the month before getting the vaccine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of flu vaccines (one with an added ingredient to boost the immune response and one without) in people with HIV who are 50 or older. It aims to see which vaccine produces a stronger antibody response, which may help improve flu protection.
This study compares two types of flu shots for people 65 and older to see which works better. If you are a Kaiser Permanente member and get your flu shot at a Kaiser facility, this trial looks at your health records to see how well the vaccine protected you.
This study looks at how your immune system (your body’s infection-fighting system) responds after you get the seasonal flu vaccine. It may help researchers understand what the vaccine triggers in people working in healthcare and labs.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This trial is testing a new mRNA-based flu vaccine in healthy adults. It aims to see if the vaccine is safe and effective at preventing influenza.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.